A detailed history of Daiwa Securities Group Inc. transactions in Spring Works Therapeutics, Inc. stock. As of the latest transaction made, Daiwa Securities Group Inc. holds 291 shares of SWTX stock, worth $10,077. This represents 0.0% of its overall portfolio holdings.

Number of Shares
291
Previous 251 15.94%
Holding current value
$10,077
Previous $9,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$32.04 - $42.76 $1,281 - $1,710
40 Added 15.94%
291 $9,000
Q4 2022

Feb 06, 2023

BUY
$21.73 - $28.72 $1,455 - $1,924
67 Added 36.41%
251 $7,000
Q2 2022

Aug 09, 2022

BUY
$18.36 - $60.07 $734 - $2,402
40 Added 27.78%
184 $5,000
Q4 2021

Feb 03, 2022

SELL
$53.3 - $75.84 $1,279 - $1,820
-24 Reduced 14.29%
144 $9,000
Q3 2021

Nov 05, 2021

BUY
$62.66 - $88.26 $4,762 - $6,707
76 Added 82.61%
168 $11,000
Q4 2020

Feb 04, 2021

BUY
$48.36 - $77.92 $4,449 - $7,168
92 New
92 $7,000

Others Institutions Holding SWTX

About SpringWorks Therapeutics, Inc.


  • Ticker SWTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,401,100
  • Market Cap $2.16B
  • Description
  • SpringWorks Therapeutics, Inc. acquires, develops, and commercializes medicines for underserved patient populations suffering from rare diseases and cancer. Its lead product candidate is nirogacestat, an oral small molecule gamma secretase inhibitor that is in Phase III clinical trial for the treatment of desmoid tumors. The company is also deve...
More about SWTX
Track This Portfolio

Track Daiwa Securities Group Inc. Portfolio

Follow Daiwa Securities Group Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Daiwa Securities Group Inc., based on Form 13F filings with the SEC.

News

Stay updated on Daiwa Securities Group Inc. with notifications on news.